Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Meta Platforms (Facebook)
META
|
+$479M |
| 3 |
Evergy
EVRG
|
+$302M |
| 4 |
Johnson & Johnson
JNJ
|
+$298M |
| 5 |
Walmart
WMT
|
+$266M |
Top Sells
| 1 |
Home Depot
HD
|
+$623M |
| 2 |
Amazon
AMZN
|
+$555M |
| 3 |
Booking.com
BKNG
|
+$519M |
| 4 |
Eli Lilly
LLY
|
+$279M |
| 5 |
UnitedHealth
UNH
|
+$251M |
Sector Composition
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.44% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Bankwell Financial Group
BWFG
$359M
| $5.95M | 0.01% |
184,900
+10,600
| +6% | +$341K |
|
1677
Materion
MTRN
$2.31B
| $5.94M | 0.01% |
109,700
+35,600
| +48% | +$1.93M |
|
|
TERP
1678
DELISTED
TerraForm Power, Inc
TERP
| $5.92M | 0.01% |
505,680
+285,100
| +129% | +$3.34M |
|
|
GFN
1679
DELISTED
General Finance Corporation
GFN
| $5.91M | 0.01% |
436,315
+194,615
| +81% | +$2.64M |
|
|
SRT
1680
DELISTED
Startek Inc.
SRT
| $5.91M | 0.01% |
939,600
+89,400
| +11% | +$562K |
|
1681
Bank of New York Mellon
BK
$75.1B
| $5.9M | 0.01% |
109,477
-392,100
| -78% | -$21.1M |
|
|
ARC
1682
DELISTED
ARC Document Solutions, Inc.
ARC
| $5.89M | 0.01% |
3,328,381
+298,001
| +10% | +$527K |
|
1683
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $5.89M | 0.01% |
229,100
+53,400
| +30% | +$1.37M |
|
1684
Kimball Electronics
KE
$741M
| $5.86M | 0.01% |
320,275
-8,500
| -3% | -$156K |
|
1685
Element Solutions
ESI
$6.36B
| $5.85M | 0.01% |
504,200
+484,500
| +2,459% | +$5.62M |
|
1686
Rocky Mountain Chocolate Factory
RMCF
$12.1M
| $5.84M | 0.01% |
510,185
+9,608
| +2% | +$110K |
|
|
VVUS
1687
DELISTED
Vivus Inc
VVUS
| $5.83M | 0.01% |
827,380
+42,310
| +5% | +$298K |
|
1688
Grupo Aeroportuario del Sureste
ASR
$10.4B
| $5.83M | 0.01% |
36,600
+3,500
| +11% | +$557K |
|
|
LORL
1689
DELISTED
Loral Space and Communications, Inc.
LORL
| $5.82M | 0.01% |
+154,700
| New | +$5.82M |
|
1690
Arrow Electronics
ARW
$6.61B
| $5.8M | 0.01% |
77,100
-20,500
| -21% | -$1.54M |
|
|
EXPR
1691
DELISTED
Express, Inc.
EXPR
| $5.79M | 0.01% |
31,650
-1,779
| -5% | -$326K |
|
|
SPNE
1692
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $5.78M | 0.01% |
458,000
+25,608
| +6% | +$323K |
|
|
AFSI
1693
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $5.78M | 0.01% |
+396,712
| New | +$5.78M |
|
1694
First Bancorp
FNLC
$301M
| $5.77M | 0.01% |
204,600
+20,500
| +11% | +$579K |
|
1695
German American Bancorp
GABC
$1.53B
| $5.77M | 0.01% |
160,950
+61,450
| +62% | +$2.2M |
|
|
ITCI
1696
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.75M | 0.01% |
325,476
-219,524
| -40% | -$3.88M |
|
1697
Sun Life Financial
SLF
$33.2B
| $5.75M | 0.01% |
143,100
+124,800
| +682% | +$5.01M |
|
1698
iShares Russell 2000 ETF
IWM
$66.9B
| $5.75M | 0.01% |
35,100
-2,800
| -7% | -$459K |
|
1699
UroGen Pharma
URGN
$869M
| $5.75M | 0.01% |
115,451
-41,249
| -26% | -$2.05M |
|
1700
Aptevo Therapeutics
APVO
$4.83M
| $5.74M | 0.01% |
3
+1
| +50% | +$1.91M |
|